| Issue |
Med Sci (Paris)
Volume 29, Number 6-7, Juin–Juillet 2013
|
|
|---|---|---|
| Page(s) | 574 - 576 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2013296007 | |
| Published online | 12 July 2013 | |
MiR-142-3p et leucémogenèse
Suppresseur de tumeur ou oncomiR ?
MiR-142-3p in leukaemogenesis: tumour suppressor or oncomiR?
1
U866 Inserm, faculté de médecine, Université de Bourgogne, 7 boulevard Jeanne d’Arc, 21000 Dijon, France
2
U1009 Inserm, Institut Gustave Roussy, Université Paris-Sud 11, 114 rue Edouard Vaillant, 94805 Villejuif, France
*
Laurent.Delva@u-bourgogne.fr
Cet article ne possède pas de résumé.
© 2013 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
